BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Marksans Pharma Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
524404
ISIN Demat
INE750C01026
Book Value (Rs)
36.4615746
NSE Symbol
MARKSANS
Divident Yield %
0.35
Market Cap
(Rs In Cr.)
11,606
P/E (TTM)
38.57
EPS (TTM)
6.64
Face Value
(Rs)
1
Back
Marksans Pharma consolidated net profit rises 8.26% in the December 2025 quarter
05-Feb-26   Hrs IST

Net profit of Marksans Pharma rose 8.26% to Rs 113.20 crore in the quarter ended December 2025 as against Rs 104.56 crore during the previous quarter ended December 2024. Sales rose 10.64% to Rs 754.43 crore in the quarter ended December 2025 as against Rs 681.85 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales754.43681.85 11
OPM %21.3120.35 -
PBDT174.95163.95 7
PBT150.62143.26 5
NP113.20104.56 8

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)